Psyence Biomedical Ltd. SEC filings PBMWW
Psyence Biomedical Ltd. has 170 filings in SEC EDGAR's recent list, going back to Aug 1, 2023. Its latest annual report, Form 20-F, was filed on Jun 22, 2026 for the period ended Mar 31, 2026. The most recent current report (Form 6-K) was filed on Oct 21, 2026. The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Oct 21, 2026 | Oct 21, 2026 |
| 6-K | Current report (foreign issuer) | Oct 5, 2026 | Oct 5, 2026 |
| 6-K | Current report (foreign issuer) | Sep 28, 2026 | Sep 28, 2026 |
| 6-K | Current report (foreign issuer) | Sep 23, 2026 | Sep 23, 2026 |
| 6-K | Current report (foreign issuer) | Sep 14, 2026 | Sep 14, 2026 |
| EFFECT | Filing | Sep 1, 2026 | — |
| S-8 | Employee stock plan registration | Aug 26, 2026 | — |
| F-3 | Shelf registration (foreign issuer) | Aug 26, 2026 | — |
| 6-K | Current report (foreign issuer) | Aug 6, 2026 | Aug 6, 2026 |
| 20-F | Annual report (foreign issuer) | Jun 22, 2026 | Mar 31, 2026 |
| 6-K | Current report (foreign issuer) | Jun 5, 2026 | Jun 5, 2026 |
| 6-K | Current report (foreign issuer) | Apr 23, 2026 | Apr 23, 2026 |
| 6-K | Current report (foreign issuer) | Apr 20, 2026 | Apr 20, 2026 |
| 6-K | Current report (foreign issuer) | Apr 17, 2026 | Apr 17, 2026 |
| 6-K | Current report (foreign issuer) | Apr 15, 2026 | Apr 14, 2026 |
| 6-K | Current report (foreign issuer) | Mar 2, 2026 | Mar 2, 2026 |
| 6-K | Current report (foreign issuer) | Feb 20, 2026 | Feb 19, 2026 |
| 6-K | Current report (foreign issuer) | Feb 19, 2026 | Feb 19, 2026 |
| 6-K | Current report (foreign issuer) | Feb 13, 2026 | Feb 13, 2026 |
| 6-K | Current report (foreign issuer) | Feb 12, 2026 | Feb 12, 2026 |
| 6-K | Current report (foreign issuer) | Jan 29, 2026 | Jan 29, 2026 |
| 6-K | Current report (foreign issuer) | Jan 27, 2026 | Jan 27, 2026 |
| 6-K | Current report (foreign issuer) | Jan 14, 2026 | Jan 14, 2026 |
| 6-K | Current report (foreign issuer) | Jan 13, 2026 | Jan 13, 2026 |
| 6-K/A | Current report | Jan 13, 2026 | Jan 12, 2026 |
| 6-K | Current report (foreign issuer) | Jan 8, 2026 | Jan 8, 2026 |
| 6-K | Current report (foreign issuer) | Nov 21, 2025 | Nov 21, 2025 |
| 424B3 | Prospectus | Nov 20, 2025 | — |
| 6-K | Current report (foreign issuer) | Nov 20, 2025 | Sep 30, 2025 |
| 424B3 | Prospectus | Nov 12, 2025 | — |
| 6-K | Current report (foreign issuer) | Nov 10, 2025 | Nov 10, 2025 |
| 424B3 | Prospectus | Nov 3, 2025 | — |
| F-1/A | Amendment no. 2 to form f-1 | Oct 14, 2025 | — |
| 6-K | Current report (foreign issuer) | Oct 9, 2025 | Oct 9, 2025 |
| F-1/A | Amendment no. 1 to form f-1 | Oct 6, 2025 | — |
| CORRESP | Letter to the SEC | Oct 6, 2025 | — |
| 6-K | Current report (foreign issuer) | Sep 5, 2025 | Sep 5, 2025 |
| 6-K | Current report (foreign issuer) | Aug 28, 2025 | Aug 28, 2025 |
| UPLOAD | Letter from the SEC | Aug 13, 2025 | — |
| F-3 | Shelf registration (foreign issuer) | Aug 6, 2025 | — |
| 20-F/A | Amended annual report (foreign issuer) | Jul 25, 2025 | Mar 31, 2025 |
| S-8 | Employee stock plan registration | Jul 23, 2025 | — |
| 20-F | Annual report (foreign issuer) | Jun 25, 2025 | Mar 31, 2025 |
| 6-K | Current report (foreign issuer) | Jun 25, 2025 | Jun 25, 2025 |
| 6-K | Current report (foreign issuer) | Jun 11, 2025 | Jun 11, 2025 |
| 6-K | Current report (foreign issuer) | May 20, 2025 | May 20, 2025 |
| 6-K | Current report (foreign issuer) | May 6, 2025 | May 6, 2025 |
| 6-K | Current report (foreign issuer) | Apr 23, 2025 | Apr 23, 2025 |
| 6-K | Current report (foreign issuer) | Apr 11, 2025 | Apr 11, 2025 |
| 6-K | Current report (foreign issuer) | Apr 1, 2025 | Apr 1, 2025 |
| 6-K | Current report (foreign issuer) | Mar 31, 2025 | Mar 31, 2025 |
| EFFECT | Filing | Mar 14, 2025 | — |
| CORRESP | Letter to the SEC | Mar 13, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 11, 2025 | — |
| F-3 | Shelf registration (foreign issuer) | Mar 4, 2025 | — |
| EFFECT | Filing | Jan 30, 2025 | — |
| 424B3 | Prospectus | Jan 30, 2025 | — |
| CORRESP | Letter to the SEC | Jan 28, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 28, 2025 | — |
| F-1 | Registration statement (foreign issuer) | Jan 24, 2025 | — |
| 6-K | Current report (foreign issuer) | Jan 23, 2025 | Sep 30, 2024 |
| D | Filing | Jan 7, 2025 | — |
| EFFECT | Filing | Dec 31, 2024 | — |
| 424B3 | Prospectus | Dec 31, 2024 | — |
| 6-K | Current report (foreign issuer) | Dec 31, 2024 | Dec 31, 2024 |
| CORRESP | Letter to the SEC | Dec 30, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 27, 2024 | — |
| 6-K | Current report (foreign issuer) | Dec 23, 2024 | Dec 23, 2024 |
| F-1 | Registration statement (foreign issuer) | Dec 20, 2024 | — |
| 6-K | Current report (foreign issuer) | Dec 19, 2024 | Dec 19, 2024 |
| 6-K | Current report (foreign issuer) | Dec 18, 2024 | Dec 18, 2024 |
| 6-K | Current report (foreign issuer) | Dec 4, 2024 | Dec 4, 2024 |
| 6-K | Current report (foreign issuer) | Dec 4, 2024 | Dec 4, 2024 |
| 6-K | Current report (foreign issuer) | Dec 3, 2024 | Dec 3, 2024 |
| 6-K | Current report (foreign issuer) | Nov 22, 2024 | Nov 22, 2024 |
| 6-K | Current report (foreign issuer) | Nov 12, 2024 | Nov 12, 2024 |
| 424B3 | Prospectus | Nov 12, 2024 | — |
| EFFECT | Filing | Nov 8, 2024 | — |
| CORRESP | Letter to the SEC | Nov 6, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 6, 2024 | — |
| 6-K | Current report (foreign issuer) | Nov 1, 2024 | Nov 1, 2024 |
| F-1 | Registration statement (foreign issuer) | Oct 30, 2024 | — |
| 6-K | Current report (foreign issuer) | Oct 23, 2024 | Oct 23, 2024 |
| EFFECT | Filing | Oct 10, 2024 | — |
| 424B3 | Prospectus | Oct 10, 2024 | — |
| CORRESP | Letter to the SEC | Oct 8, 2024 | — |
| 6-K | Current report (foreign issuer) | Oct 8, 2024 | Oct 8, 2024 |
| UPLOAD | Letter from the SEC | Oct 7, 2024 | — |
| F-1 | Registration statement (foreign issuer) | Oct 2, 2024 | — |
| 6-K | Current report (foreign issuer) | Sep 20, 2024 | Sep 20, 2024 |
| 6-K | Current report (foreign issuer) | Sep 13, 2024 | Sep 13, 2024 |
| 6-K | Current report (foreign issuer) | Sep 5, 2024 | Sep 5, 2024 |
| 6-K | Current report (foreign issuer) | Aug 30, 2024 | Aug 30, 2024 |
| 424B3 | Prospectus | Aug 30, 2024 | — |
| EFFECT | Filing | Aug 28, 2024 | — |
| CORRESP | Letter to the SEC | Aug 26, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 26, 2024 | — |
| 6-K | Current report (foreign issuer) | Aug 20, 2024 | Aug 20, 2024 |
| F-1 | Registration statement (foreign issuer) | Aug 19, 2024 | — |
| 424B3 | Prospectus | Aug 19, 2024 | — |
| EFFECT | Filing | Aug 15, 2024 | — |
| POS AM | Filing | Aug 12, 2024 | — |
| 6-K | Current report (foreign issuer) | Jul 31, 2024 | Jul 31, 2024 |
| S-8 | Employee stock plan registration | Jul 31, 2024 | — |
| 20-F | Annual report (foreign issuer) | Jul 29, 2024 | Mar 31, 2024 |
| 6-K | Current report (foreign issuer) | Jul 24, 2024 | Jul 24, 2024 |
| 6-K | Current report (foreign issuer) | Jul 23, 2024 | Jul 23, 2024 |
| 6-K | Current report (foreign issuer) | Jul 5, 2024 | Jul 5, 2024 |
| 6-K | Current report (foreign issuer) | Jun 20, 2024 | Jun 20, 2024 |
| 6-K | Current report (foreign issuer) | Jun 6, 2024 | Jun 6, 2024 |
| EFFECT | Filing | May 14, 2024 | — |
| CORRESP | Letter to the SEC | May 13, 2024 | — |
| F-1/A | Filing | May 10, 2024 | — |
| CORRESP | Letter to the SEC | May 9, 2024 | — |
| UPLOAD | Letter from the SEC | May 8, 2024 | — |
| F-1/A | Filing | May 7, 2024 | — |
| CORRESP | Letter to the SEC | May 6, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 29, 2024 | — |
| CORRESP | Letter to the SEC | Apr 18, 2024 | — |
| F-1/A | Filing | Apr 18, 2024 | — |
| 6-K | Current report (foreign issuer) | Mar 15, 2024 | Mar 15, 2024 |
| 6-K | Current report (foreign issuer) | Mar 12, 2024 | Mar 12, 2024 |
| UPLOAD | Letter from the SEC | Feb 23, 2024 | — |
| F-1 | Registration statement (foreign issuer) | Feb 9, 2024 | — |
| 20-F | Annual report (foreign issuer) | Jan 31, 2024 | Jan 25, 2024 |
| CERT | Filing | Jan 26, 2024 | — |
| 8-A12B | Filing | Jan 25, 2024 | — |
| 425 | Filing | Jan 23, 2024 | — |
| 425 | Filing | Jan 17, 2024 | — |
| 425 | Filing | Nov 15, 2023 | — |
| 424B3 | Prospectus | Nov 15, 2023 | — |
| SEC STAFF LETTER | Filing | Nov 15, 2023 | — |
| EFFECT | Filing | Nov 13, 2023 | — |
| F-4/A | Filing | Nov 13, 2023 | — |
| CORRESP | Letter to the SEC | Nov 13, 2023 | — |
| F-4/A | Filing | Nov 13, 2023 | — |
| F-4/A | Filing | Nov 6, 2023 | — |
| CORRESP | Letter to the SEC | Nov 3, 2023 | — |
| UPLOAD | Letter from the SEC | Oct 25, 2023 | — |
| CORRESP | Letter to the SEC | Oct 16, 2023 | — |
| F-4/A | Filing | Oct 16, 2023 | — |
| SEC STAFF LETTER | Filing | Oct 11, 2023 | — |
| UPLOAD | Letter from the SEC | Oct 4, 2023 | — |
| CORRESP | Letter to the SEC | Sep 20, 2023 | — |
| F-4/A | Filing | Sep 20, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 4, 2023 | — |
| F-4 | Filing | Aug 1, 2023 | — |
Showing 147 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PBM (Nasdaq), PBMWW (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- Ontario, Canada
- Headquarters
- Toronto
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1985062
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.